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Background: Early accurate assessment of burn depth is important to determine the optimal treatment of burns.
The method most used to determine burn depth is clinical assessment, which is the least expensive, but not the
most accurate.
Laser Doppler imaging (LDI) is a technique with which a more accurate (>95%) estimate of burn depth can be
made by measuring the dermal perfusion. The actual effect on therapeutic decisions, clinical outcomes and the
costs of the introduction of this device, however, are unknown. Before we decide to implement LDI in Dutch burn
care, a study on the effectiveness and cost-effectiveness of LDI is necessary.
Methods/design: A multicenter randomised controlled trial will be conducted in the Dutch burn centres:
Beverwijk, Groningen and Rotterdam. All patients treated as outpatient or admitted to a burn centre within 5 days
post burn, with burns of indeterminate depth (burns not obviously superficial or full thickness) and a total body
surface area burned of ≤ 20% are eligible. A total of 200 patients will be included. Burn depth will be diagnosed by
both clinical assessment and laser Doppler imaging between 2–5 days post burn in all patients. Subsequently,
patients are randomly divided in two groups: ‘new diagnostic strategy’ versus ‘current diagnostic strategy’. The
results of the LDI-scan will only be provided to the treating clinician in the ‘new diagnostic strategy’ group. The
main endpoint is the effect of LDI on wound healing time.
In addition we measure: a) the effect of LDI on other patient outcomes (quality of life, scar quality), b) the effect of
LDI on diagnostic and therapeutic decisions, and c) the effect of LDI on total (medical and non-medical) costs and
cost-effectiveness.
Discussion: This trial will contribute to our current knowledge on the use of LDI in burn care and will provide
evidence on its cost-effectiveness.
Trial registration: NCT01489540
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In patients with burns an early accurate diagnosis of burn
depth is essential to determine the most appropriate treat-
ment. Monstrey et al. recently reviewed all current modal-
ities to diagnose burn depth. Bedside clinical examination
is the most widely used and least expensive method for
burn depth assessment. This technique is effective when* Correspondence: baarm@maasstadziekenhuis.nl
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reproduction in any medium, provided the ordiagnosing burns at the extreme end of the spectrum:
superficial or full thickness. In partial thickness burns,
however, clinical examination is not very accurate. Clinical
burn depth assessment is accurate in about 2/3 of the
cases, the most reported error is overestimation of depth
[1].
Overestimation of burn depth can lead to unnecessary
excision and grafting [2,3]. On the other hand, under-
estimation of burn depth may lead to an unnecessary
delay in surgery, with a longer length of hospital stay
and higher hospital costs as a consequence [4,5]. In burn. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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growing interest in costs and cost control [6,7]. In order
to provide effective and cost-effective burn care, there
is a need for an accurate method for burn depth
estimation.
Laser Doppler imaging (LDI) is the only technique
that has been shown to accurately predict wound depth
with a large weight of evidence [1]. Laser Doppler im-
aging is based on the Doppler principle. Laser light that
is directed at moving blood cells in sampled tissue exhi-
bits a frequency change that is proportional to the
amount of perfusion in the tissue. Laser Doppler im-
aging combines the advantages of laser Doppler and
scanning techniques: the whole burn can be sampled
and no direct contact with the burn surface is necessary
[2]. In daily practice, LDI will be used in combination
with standard clinical assessment [8], as a so-called add-
on test [9].
Several prospective studies on the diagnostic accuracy
of laser Doppler imaging have demonstrated an accuracy
varying between 95-100% [3,8,10-12]. Timing of LDI is
important: only scanning between 48 hours and 5 days
results in a high accuracy (>95%) [8,11,13,14].
To decide whether a new diagnostic strategy, like LDI,
should be implemented, assessment of diagnostic accur-
acy should be followed by assessment of diagnostic and
therapeutic impact, effectiveness and cost-effectiveness
of the new technology [9,15].
The literature on the accuracy of LDI in burn depth
assessment is convincing. However, most studies only re-
port on the accuracy of this technique. The diagnostic
and therapeutic impact of the introduction of LDI is
often only speculated upon.
There is, to our knowledge, only one retrospective co-
hort study [4], and one prospective non-randomized
study [5] that investigated the therapeutic impact of the
introduction of laser Doppler imaging. Petrie et al.
reported a lower rate of operative interventions (6.8%
before and 2.2% after, p= 0.029) in a pediatric burn
population after the introduction of LDI and a reduced
length of hospital stay of the surgical treated patients
(15.1 days before and 9.8 days after, no p-value). The
overall length of stay was 3.4 days in 235 patients before
and 2.1 days in 270 patients after the introduction of the
LDI [4]. Because of the retrospective nature of this
study, other factors than the introduction of LDI alone
could be responsible for the therapeutic changes [9]. In
the study of Kim et al. [5] the impact of LDI on sur-
gically treated pediatric patients with burns was
investigated. The mean time to decision making for
grafting procedures was shorter in the LDI group
compared to the clinically assessed group (8.9 vs.
11.6 days, p= 0.01). Because of the non-randomised
design, it is unclear whether this can be contributedto the LDI or to other differences between the
groups.
Thus, current research gives some indications on the
diagnostic and therapeutic impact of the LDI in burm
care. However, randomised studies in both pediatric and
adult patients with burns are lacking.
The introduction of LDI possibly leads to a cost reduc-
tion in burn care, by preventing unnecessary surgery
[3,4], and reducing length of hospital stay [4]. However,
no prospective studies are available on the costs and the
possible cost reduction of LDI in burn care, nor are
cost-effectiveness studies. Therefore, we can conclude
that is it still unclear whether LDI actually influences
diagnostic and therapeutic decisions, patient outcomes
and costs, and thus adds to the quality of care.
The aim of our study is to analyse the effectiveness
and cost-effectiveness of LDI in burn care. The ef-
fect of the use of LDI in burn care on decision mak-
ing, on clinical outcomes, on costs, and on cost
effectiveness will be assessed. The current diagnostic
strategy in burn depth assessment (clinical assess-
ment) is compared with the new diagnostic strategy:
LDI in combination with clinical assessment. We ex-
pect that LDI in combination with clinical assess-
ment can lead to earlier excision and grafting in
Dutch burn care. With the results of this cost-
effectiveness study, we aim to provide a guidance to
decide whether this instrument should be implemen-
ted in Dutch burn care.
Methods/design
Study design
A multicenter, randomised controlled trial will be
conducted in the three Dutch burn centres: Beverwijk,
Groningen and Rotterdam.
Participants
All consecutive patients of any ages with acute burns
of indeterminate depth (assessed by the treating clin-
ician), who are seen within 5 days post burn at one
of the three burn centres, are eligible.
Inclusion criteria:
 Patients with acute burns of indeterminate depth
(=intermediate depth; the burn wound is not
obviously superficial or obviously full thickness)
 Outpatient treatment or admission in one of the
three Dutch burn centres
 Presentation within 5 days post burn
Exclusion criteria:
 The presence of full thickness wounds, next to
intermediate wounds
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(e.g. hydrocolloid dressings)
 Patients with peri-orbital facial burns, in which the
eyes are unable to shield
 Patients or their next of kin if they are under aged
or temporary incompetent who can not be expected
to give informed consent e.g. because of cognitive
dysfunction or poor Dutch proficiency.
 Patients with a TBSA burned > 20%
Intervention
We will include a total of 200 patients and randomly
divide them in two groups: new diagnostic strategy ver-
sus current diagnostic strategy. In the first few days the
burns will be treated with regular topical antimicrobials
or dressings. LDI is performed between 48 hours and 5
days post burn in this study. After removal of the topical
agent (during regular wound care), all wounds of inde-
terminate depth are scanned by a trained research phys-
ician or nurse, who is not involved in the patient
treatment. In case of clearly superficial wounds next to
intermediate wounds in a study patient, the superficial
wounds will not be scanned; similar to what would hap-
pen in daily practice.
Results of LDI are (Figure 1): [12]
 Red/pink represents a healing potential within 14
days post burn
 Yellow/green represents a healing potential between
14–21 days
 Blue represents a healing potential > 21 days
In the group ‘new diagnostic strategy’, the results of
the LDI scan will be revealed to the treating clinician.Figure 1 Clinical appearance of a three-days-old flame burn in
a woman of 21. The LDI scan shows a burn with a healing
potential < 14 days of the right hand palm and a healing potential
> 21 days of the right lower arm. Written consent was obtained
from the participant to publish this figure.Subsequent treatment and outcome of this group will be
compared to that of the group with ‘current diagnostic
strategy’ in which the treating clinician is blinded for the
results of the LDI scan.
Outcomes
Primary outcome measure: wound healing time
Wound healing time is defined as the number of days
between LDI (randomisation) and the day on which ree-
pithelialisation of >95% is achieved. Next to that, for
generalisation and LDI accuracy checks, we will present
the time to wound healing from the day of injury. Dur-
ing wound care an experienced burn specialist will as-
sess reepithelialisation; this is a reliable and valid
technique (compared to digital image analysis) [16].
Wounds in admitted patients are assessed daily and
wounds in outpatients two or three times a week. Differ-
ences in wound healing time between the two random-
isation groups will be analysed.
Secondary outcomes measures:
Quality of life and scar quality Quality of life will be
measured as soon as possible after injury to determine
pre-injury functioning (at least within one month post
burn) and after 3 months with the EuroQol-6D (Euro-
Qol-5D + cognitive functioning; validated in patients
aged ≥ 5 years) or the ItQol-47 questionnaire (validated
in children < 5 years of age) [17-19].
The EuroQol-5D questionnaire can result in 243
different health states, which can be converted in
a summary (utility) score between 0 (death) and 1
(perfect health) [18]. The EuroQol (EQ-5D) is an ex-
tensively used general health questionnaire to measure
quality of life. It is recommended for the assessment
of HRQoL in injury patients, especially for economic
assessments [20].
Scar quality will be measured 3 months post-injury.
Scar quality will be measured as follows;
 Elasticity will be measured with the CutometerW
Skin Elasticity Meter 575 (Courage and Khazaka
Electronic GmbH, Cologne, Germany) The
cutometer provides several elasticity parameters. In
this study, maximal skin extension (Uf) (in mm) will
be used, because this has been demonstrated to be
the most reliable parameter [21].
 Vascularity and pigmentation will be measured with
the Dermaspectometer, which is a reliable
narrowband spectrometer that computes an
erythema and melanin index (Cortex Technology,
Hadshund, Denmark) [22].
 Subjective scar assessment will be performed by
means of the Patients Observer Scar Assessment
Scale (POSAS), a reliable and valid scar assessment
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[22,23]. The patient scores the scar characteristics
colour, pliability, thickness, relief, itching and pain.
The observer scale contains the items
vascularisation, pliability, pigmentation, thickness,
and relief. All items are scored numerically on a 10-
point rating scale. In addition, the two observers and
the patient give a general opinion on the scare
quality on a 10-point rating scale.
Differences in quality of life and scar quality 3 months
post burn between the two diagnostic groups will be
analysed.Diagnostic decisions: diagnostic effect of LDI and ac-
curacy In the ‘new diagnostic strategy’ group the diag-
nostic effect of the introduction of LDI will be assessed
on the scanning day by comparing diagnostic decisions
of burn clinicians, just before and after the use of LDI.
Possible diagnostic decisions before LDI are:
 Superficial partial thickness burn (no study wound)
 Intermediate burn, the burn wound is not obviously
superficial or full thickness (if parts of a burn wound
are obviously full thickness, this will be recorded
also)
 Deep partial thickness of full thickness burn
(exclusion patient from study)
Possible diagnostic decisions after LDI are [12]:
 Superficial partial thickness burn, will heal within 14
days
 Intermediate partial thickness burn, will heal
between 14–21 days (the spectrum of an
‘intermediate burn’ is smaller after the use of LDI
compared to before the use of LDI)
 Deep partial thickness or full thickness burn, will
not heal within 21 days
Accuracy of LDI in our study patients will be checked
also. Results of laser Doppler imaging are compared with
the reference tests: time of wound healing (from burn
date until >95% reepithelialisation) and biopsies. In our
study protocol, wounds with a healing potential ≤ 21
(assessed by the LDI) are considered as superficial or
intermediate partial thickness and wounds with a healing
potential > 21 days are considered as deep partial thick-
ness or full thickness. Only in case of surgery a 3 mm-
punch biopsy will be taken as a reference test to assess
burn depth [1]: in a superficial burn the basal membrane
is partially destroyed; in a deep partial thickness burn
the basal membrane is entirely destroyed and the dermispartially destroyed; in a full thickness burn, the dermis is
also completely destroyed.Therapeutic decisions: timing of surgery indication,
timing of surgery and length of hospital stay The ef-
fect of LDI on therapeutic decisions by the burn clin-
ician will be assessed. The first therapeutic decision is
on admittance, the second monitored decision is after
2–5 days (based on clinical assessment or clinical assess-
ment in combination with LDI result). In case of post-
ponement of decision, reason of postponement will be
investigated and decision making is followed until
wound healing.
The possible therapeutic decisions are:
 Surgery
 Postponement of decision
 No surgery
Differences in therapeutic decisions on the day of ran-
domisation will be analysed.
In case of surgery, differences in timing of surgical
decision and timing of surgery (in days after randomisa-
tion) between the two diagnostic groups will be
analysed.
Differences in length of hospital stay between the two
diagnostic groups will be analysed as well.Economic evaluation: total costs and cost-effective-
ness The economic evaluation will be performed from
a societal perspective in accordance with the Dutch
guidelines for economic evaluation studies [24]. A cost-
effectiveness analysis will assess the balance between costs
and effects of the new diagnostic strategy compared to the
current diagnostic strategy.
Total costs in this study represent direct healthcare
costs (inpatient and outpatient medical costs), direct
non-healthcare costs (travel costs) and indirect non-
healthcare costs (productivity loss). Real medical costs
will be calculated by multiplying the volumes of health
care use with the corresponding unit prices. Costs will
be calculated from randomisation until 3 months post
burn. A bottom up approach will be applied (following
the micro-costing method of Gold et al. 1996) based on
a detailed inventory of all resource used during admit-
tance in one of the Dutch burn centres [25].
Cost prizes will be inventoried in the financial depart-
ment of one burn centre and will be used for all centres
in order to prevent measuring cost differences between
burn centres. The costs apply to the financial year 2012.
Specialized burn care costs include intervention costs,
hospital days, and other variable costs:
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determined by taking into account the initial
investment of equipment, investments during use,
maintenance, numbers of years of use, discounting,
number of procedures per year and personnel costs.
 Hospital day (both ICU and non ICU) costs will be
calculated by multiplying the length of hospital stay
by the costs of one day of admission. The cost of re-
admittance during follow-up will also be calculated.
The costs of a day of admittance are based on a
detailed inventory (following the micro-costing
method of Gold et al. 1996) of fixed costs only:
staffing costs, accommodation, equipment, overhead,
food, laundry, and medication [25].
 Variable hospital costs will be identified per patient
and calculated by multiplying the volumes of health
care use with the corresponding unit prices. The
included items are: dressing costs, surgical
procedures (material, equipment and personnel
costs), diagnostic procedures (bronchoscopy, swabs,
laboratory and radiology costs), treatment by allied
health professionals, splints, pressure garments, and
outpatient visits (staffing and material costs).
Data registration will start on the day of randomisa-
tion. Data regarding patients’ baseline characteristics
and health-care use will be obtained from patient
records and the electronic hospital administration.
Other healthcare costs and non healthcare costs will be
calculated based on charges as a proxy of real costs [24]
with the help of data obtained from patient question-
naires after 3 months. Other healthcare costs include
nursing-home and rehabilitation centre, homecare, visits
to general physicians and allied health professional out-
side the hospital. Indirect non-healthcare costs include
productivity loss in patients and partners or parents
(if applicable), and direct non-healthcare costs include
patient travel costs.
To measure the economic impact of LDI in burn care
cost-effectiveness will be assessed by calculating the in-
cremental cost-effectiveness ratio, defined here as the
costs for the ‘new diagnostic strategy’ (minus savings)
divided by the difference in wound healing time (mea-
sured from randomisation) between the ‘new diagnostic
strategy’ and ‘current diagnostic strategy’. Secondary, a
cost-utility analysis will be performed, i.e., as cost per
Quality Adjusted Life Years (QALY). The cost-utility
ratio can be calculated in patients ≥ 5 years only. In chil-
dren under the age of 5 years, the EuroQol-5D is not
validated and no questionnaires are available that allow
the calculation of utility scores [18,19]. Overall utility
scores for population-based quality of life (derived from
the EuroQol-5D) will be obtained and expressed as
QALY’s. QALY’s will be calculated by multiplying theutility of a health state by the time spent in this health
state using the Dutch valuation tariff [26]. Policymakers
and health economists have proposed that costs varying
from €25,000 up to €75,000 per QALY may be consid-
ered as acceptable [27]. In accordance with guidelines
for differential discounting, effects will be discounted at
a rate of 1.5% and costs at 4% per year [24].
In case no differences will be found in wound healing
and quality of life, the economic evaluation will be based
on a cost-minimisation analysis, that consists of a com-
parison of total costs in both diagnostic strategies.Sample size
A total of 57.5% of admitted burn patients in the Neth-
erlands is treated conservatively (unpublished data,
Dutch Burn Repository R3, 2011). The time to wound
healing in patients without surgery is approximately 13
days, this will not change after the introduction of LDI.
In the 42.5% of surgically treated patients we do expect
an effect on wound healing time, because of an earlier
operation. The mean time to first transplantation is 14.0
days post burn, the mean time to wound healing is 5
days after surgery [28], resulting in a mean time to
wound healing of 19.0 days. The overall mean time to
wound healing for all patients combined is 15.6 days
((57.5%*13+ 42.5%*19)/100).
Petrie et al. describe a reduction of 5.3 days in LOS in
patients undergoing surgery, after the introduction of
the LDI. As a result, in our population, an overall effect
of 2.25 (57.5%* 5.3) days can be expected, with a stand-
ard deviation of 5 days. A 2-sided test with an α level of
0.05 and a β level of 0.20 (power 0.80) indicates a
required total sample size of 190 patients. We expect a
low drop out rate because of a short time to follow up
to assess primary outcome (time to wound healing).
With a 5% drop out we need a total sample size of 200.
Randomisation
Patients are randomly allocated to the group ‘new diag-
nostic strategy’ or the group ‘current diagnostic strategy’,
on the day of the LDI scan. Stratification will be per-
formed for the three different centers and the severity of
the burns: total burned surface area ≤10% or >10%. A
randomisation list is prepared for each stratum on the
principle of random permuted blocks of patients, using a
random number table [29]. The allocation sequence is
concealed by using sequentially numbered, opaque
sealed envelopes (SNOSE) prepared by the coordinating
researcher (MJH) which are opened at day of LDI after
having obtained informed consent, by one of the local
researchers [30].
The care provider, outcome assessor and patients are
blinded to the results of the LDI in the group ‘current
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group in which patients are randomised.
Statistical analysis
Data will be primarily analysed according to the
intention-to-treat principle. We assume that time to LDI
will be equal in both diagnostic groups, as a result of
randomisation. Thus, the differences in effects (e.g. time
to wound healing) and costs will be assessed from ran-
domisation onwards.
Differences in time to wound healing (numbers of days
between LDI and day of > 95% reepithelialisation) and
timing of surgery in both diagnostic strategy groups will
be analysed with Kaplan-Meier curves and log rank test.
Quality of life (derived from the ItQol-47 and
EuroQol-6D), scar quality (assessed by the CutometerW,
DermaspectometerW and POSAS) and length of hospital
stay will be analysed using the independent-sample-t-test
(in case of normal distribution) or the Mann–Whitney
test (non-normal distribution).
Differences in diagnostic and therapeutic decisions will
be analysed with the Chi-square test. Diagnostic accur-
acy will be assessed by calculating sensitivity and specifi-
city of the LDI compared to the reference test: time to
wound healing (in conservative treated patients) or bi-
opsy (in surgical treated patients). In addition, receiver
operating characteristic (ROC) curves will be calculated
for both diagnostic groups.
Differences in mean costs (after randomisation) will be
analysed by the Mann–Whitney test, since healthcare
costs are typically highly skewed. Non-parametric tech-
niques (bootstrapping) will be used to derive a 95% con-
fidence interval for the differences in distributions of the
costs.
The cost-effectiveness analysis and cost-utility analysis
are performed by dividing the differences in average
costs by the differences in average effects or utility. In a
sensitivity analysis, the impact on cost-effectiveness of
statistical uncertainty on the main study outcomes will
be determined (uni- and multivariable).
Data analysis will be performed using SPSS-software
(Statistical Package for the Social Sciences).
Discussion
In this paper we described the design of our study into
the effects and cost-effectiveness of laser Doppler im-
aging in Dutch burn care. This is the first randomised
controlled study that analyses not only the accuracy, but
also the effects and costs of the introduction of LDI in
burn care. Strengths of our study are the extensive cost
calculations (not only LDI costs are included) and the
detailed analysis of the possible impact of the introduc-
tion of the LDI in terms of process changes, i. e. changes
in diagnosis and therapy. A limitation of this study isthat the cost calculations will be performed in Dutch
burn centres only. Although the multicentre analysis
improves the generalisability of the cost distribution,
compared to a monocentre analysis, total cost and
cost distribution in other countries are probably
different [31].
Another limitation of this study is that it tests the ef-
fectiveness of the introduction of LDI, so there’s a pos-
sible learning effect in the study. In the first patients,
professionals will less likely rely on LDI and adapt their
therapy. As a result, differences between randomisation
groups will probably be smaller, and subsequently our
study underestimates the full effect of the introduction
of LDI in burn care.
Next to a time effect, there will probably also be an ef-
fect of differences in study sites. The usual care differs
between study sites; this can influence the results of the
introduction of LDI in the burn centres. These possible
differences will be studied by providing sub-analyses per
burn centre.
This study will undoubtedly contribute to our know-
ledge about the use of LDI in burn care and will provide
evidence on its cost-effectiveness. Inclusion of patients
started in December 2011 and presentation of data will
be expected at the end of 2013.
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